Home › Vertex And CRISPR Therapeutics Establish Collaboration To Use CRISPR-Cas9 Gene Editing Technology To Discover And Develop New Treatments For Genetic Diseases
 

Keywords :   


Vertex And CRISPR Therapeutics Establish Collaboration To Use CRISPR-Cas9 Gene Editing Technology To Discover And Develop New Treatments For Genetic Diseases

2015-11-03 04:16:23| drugdiscoveryonline Home Page

Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics recently announced that the two companies have entered into a strategic research collaboration focused on the use of CRISPR’s gene editing technology, known as CRISPR-Cas9, to discover and develop potential new treatments aimed at the underlying genetic causes of human disease

Tags: technology develop discover establish

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
02.05Apex stresses sustainability with EcoProven GTT at drupa
02.05Durst announces 1,000th installation of Durst Workflow software
02.05Milestone for Transition to Sustainable Carbon in Europe
02.05Blue Lizard Is Official Sunscreen for Dollywood Resort Parent Company Herschend
02.05Illinois Bacon Day shines light on state's pork industry
02.05Hospeco Completes Integration of Innocore
02.05AD Procerta receives ISO 17025 accreditation
02.05Silab\'s Skincare Active, Inclusium, Wins Award
More »